Delta, Pepsi, Philip Morris International and Darden Restaurants just some names facing questions about how weight-loss drugs could affect their bottom line.
Once hot freight startups including Flexport and Convoy have been humbled by a shipping recession and Uber Freight CEO Lior Ron says pressure will continue.
Piper Sandler analyst Allison Bratzel said the loss of lean muscle while taking GLP-1 drugs is "a major shortcoming" that could have bigger consequences.